Regulations surrounding mobile medical apps will be discussed during a webinar hosted by leading smartphone diagnostics specialist Novarum™ DX.
The session will focus on the regulation of mobile apps with a medical purpose, exploring its role as the future of healthcare shifts towards remote and decentralised point-of-care testing (POCT).
‘How are mobile apps regulated?’ will take place on Thursday 19th July (15:30 BST). The webinar will examine the regulatory requirements and processes needed to develop a mobile medical app to satisfy FDA and CE Marking approval.
Novarum’s Head of Regulated Product, Dr Alasdair Christie, who has over 25 years’ experience in developing technologies, will host the regulatory webinar.
Dr Christie commented: “As the healthcare industry continues to evolve, we’re noticing a shift towards the use of more decentralised point of care testing methods. As a result, understanding the regulations around mobile medical app development will be essential. Our latest in a series of webinars will cover some of the key topics that must be considered by developers and quality teams.”
Topics covered during the webinar will include; what constitutes a mobile medical app, developing apps in a regulated environment, deliverables for EU and US requirements, app development lifecycle and controls and how to maintain validation of medical apps.
Novarum’s innovative technology leverages mobile phone connectivity and app development to transform a smartphone into a diagnostic reader. Its patented image-capture software enables rapid tests for toxicology, infectious or auto-immune disease to be accurately read using nothing more than a smartphone. Test results are shared securely to a dedicated portal which is accessible by healthcare professionals online.
To enquire about Novarum’s mobile medical app webinar, visit: https://www.novarumdx.com/event/medical-app-regulations/ or email:enquiries@novarumdx.com to find out more.
If you’d like to learn more about Novarum DX, visit: www.novarumdx.com
